Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

In a new study, colon cancer patients who took GLP-1 medications saw an increase in 5-year survivorship compared with patients who didnt take GLP-1s. The increase in survivorship was greatest in ...

Weight loss and diabetes drugs such as Ozempic and Wegovy may help reduce colon cancer risk, a new study presented at the ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...

Researchers have been examining other potential health benefits from GLP-1 agonist medications outside of type 2 diabetes management and weight loss. Recent studies have found that GLP-1 medications ...

Colon cancer patients taking GLP-1 drugs, like Ozempic, had better odds of survival in a new study. Weight loss and diabetes injections have well-known anti-inflammatory benefits. It could be that ...

# “While aspirin has been studied for colorectal cancer prevention, its modest benefit and bleeding risks limit its use.

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...